This was the stock's second consecutive day of gains.

Fevertree Drinks' recent strategic partnership with Molson Coors is set to accelerate its growth in the U.S. See why FQVTF ...

Fintel reports that on February 5, 2025, Citigroup upgraded their outlook for Molson Coors Beverage (NYSE:TAP) from Sell to ...

Molson Coors Beverage (NYSE:TAP – Get Free Report) has been assigned an average rating of “Hold” from the fourteen analysts that are presently covering the stock, MarketBeat reports. One equities ...

Citi upgraded Molson Coors (TAP) to Neutral from Sell with a price target of $57, up from $47. The firm says its fundamental thesis has largely ...

Greenleaf Trust lowered its position in shares of Molson Coors Beverage (NYSE:TAP – Free Report) by 12.9% during the fourth ...

The deal gives Molson Coors exclusive commercialization rights to Fever-Tree’s U.S. portfolio, alongside an equity investment by Molson Coors into Fevertree Drinks plc CHICAGO--(BUSINESS WIRE ...

CHIPPEWA FALLS, Wis. (WEAU) - Dick and Jake Leinenkugel followed up their initial request to discuss the purchase of the ...

CHICAGO, January 30, 2025--(BUSINESS WIRE)--Molson Coors Beverage Company ("Molson Coors" or "the company") (NYSE: TAP, TAP.A) is expanding its U.S. non-alc portfolio through a new strategic ...

Wells Fargo analyst Christopher Carey maintained a Buy rating on Molson Coors (TAP – Research Report) yesterday and set a price target of $74.00. Christopher Carey’s rating is based on Molson ...

Molson Coors Beverage Company TAP has signed a deal with Fevertree Drinks plc (Fever-Tree), a global leader in premium carbonated beverages and mixers. The partnership is aimed at broadening its U ...

Molson Coors gains exclusive US rights to Fevertree products CEO says fits 'squarely' into non-alcoholic space Jefferies sees deal as a game changer for Fevertree Fevertree, which generates more ...